An optogenetic cell therapy to restore control of target muscles in an aggressive mouse model of amyotrophic lateral sclerosis
eLife · 2024
DOI: 10.7554/elife.88250 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2024. Verfasst von J Barney Bryson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Motor Neurone Disease Association, Medical Research Council, UCLH Biomedical Research Centre.
Abstract (Originalsprache)
Breakdown of neuromuscular junctions (NMJs) is an early pathological hallmark of amyotrophic lateral sclerosis (ALS) that blocks neuromuscular transmission, leading to muscle weakness, paralysis and, ultimately, premature death. Currently, no therapies exist that can prevent progressive motor neuron degeneration, muscle denervation, or paralysis in ALS. Here, we report important advances in the development of an optogenetic, neural replacement strategy that can effectively restore innervation of severely affected skeletal muscles in the aggressive SOD1 G93A mouse model of ALS, thus providing an interface to selectively control the function of targeted muscles using optical stimulation. We also identify a specific approach to confer complete survival of allogeneic replacement motor neurons. Furthermore, we demonstrate that an optical stimulation training paradigm can prevent atrophy of reinnervated muscle fibers and results in a tenfold increase in optically evoked contractile force. Together, these advances pave the way for an assistive therapy that could benefit all ALS patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
- UCL Queen Square Motor Neuron Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
- Department of Electronic and Electrical Engineering, University College London, London, United Kingdom.
ORCID-Profile: J Barney Bryson, Linda Greensmith
Förderung
- Motor Neurone Disease Association
- Medical Research Council
- UCLH Biomedical Research Centre
- Rosetrees Trust
- Richard Stravitz Foundation
- Thierry Latran Foundation
- Brain Research UK
Zitieren
APA
Bryson, J. B., Kourgiantaki, A., Jiang, D., Demosthenous, A., & Greensmith, L. (2024). An optogenetic cell therapy to restore control of target muscles in an aggressive mouse model of amyotrophic lateral sclerosis. eLife. https://doi.org/10.7554/elife.88250
Vancouver
Bryson JB, Kourgiantaki A, Jiang D, Demosthenous A, Greensmith L. An optogenetic cell therapy to restore control of target muscles in an aggressive mouse model of amyotrophic lateral sclerosis. eLife. 2024. doi:10.7554/elife.88250
BibTeX
@article{Bryson2024,
author = {Bryson, J Barney and Kourgiantaki, Alexandra and Jiang, Dai and Demosthenous, Andreas and Greensmith, Linda},
title = {An optogenetic cell therapy to restore control of target muscles in an aggressive mouse model of amyotrophic lateral sclerosis},
journal = {eLife},
year = {2024},
doi = {10.7554/elife.88250}
}
EUVIMED